Patient Guide: The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 34 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT03805789
Status: 🟢 Enrolling Now
Condition: Acute-graft-versus-host Disease
Phase: PHASE2, PHASE3

Where You Can Participate

This study is available at 34 locations across the country.

Top locations include:
  • • Scottsdale, Arizona
  • • St. Petersburg, Florida
  • • Atlanta, Georgia
  • • And 31 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant - Join Clinical Trial NCTNCT03805789

How to Join This Clinical Trial - NCTNCT03805789

Learn how to participate in this PHASE2, PHASE3 trial studying an investigational therapy for Acute-graft-versus-host Disease. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acute-graft-versus-host Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acute-graft-versus-host Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2, PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT03805789 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 34 locations. Find a study site near you:

Clinical Research Site

Scottsdale, Arizona 85258 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

St. Petersburg, Florida 33701 - United States

Status: RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: RECRUITING

Clinical Research Site

Westwood, Kansas 66205 - United States

Status: RECRUITING

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: RECRUITING

Clinical Research Site

Ann Arbor, Michigan 48109 - United States

Status: RECRUITING

Clinical Research Site

Durham, North Carolina 27705 - United States

Status: COMPLETED

Clinical Research Site

Cleveland, Ohio 44106 - United States

Status: RECRUITING

Clinical Research Site

San Antonio, Texas 77030 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Salt Lake City, Utah 84113 - United States

Status: ACTIVE_NOT_RECRUITING

And 24 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2, PHASE3 clinical trial for Acute-graft-versus-host Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships